VRTX - Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 15 Years | Benzinga
Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 15 years by 6.13% on an annualized basis producing an average annual return of 19.77%. Currently, Vertex Pharmaceuticals has a market capitalization of $106.16 billion.
Buying $1000 In VRTX: If ...